Increased intestinal absorption in the rat caused by sodium lauryl sulphate, and its possible relation to the cAMP system.
The increases in the absorption of ouabain, phenolsulphonphthalein and pralidoxime caused by 17 mM sodium lauryl sulphate (SLS) from jejunal loops of anaesthetized rats were significantly reduced if sodium and chloride (Briseid et al., 1974) or chloride and bicarbonate were replaced by other ions in the loop fluid. Separate substitutions of sodium, chloride of bicarbonate did not significantly alter the SLS-caused absorption, except that the substitution of choline for sodium reduced the absorption of pralidoxime, both in the presence and in the absence of SLS. The increases in the absorption of phenolsulphonphthalein and pralidoxime caused by SLS were potentiated by theophylline (25 mM) and reduced by imidazole (25 mM). The addition of dibutyryl cyclic AMP (2.5 mM) to the loop fluid increased this absorption of the test substances. This effect was reduced by imidazole, but under the experimental conditions it was not potentiated by theophylline. Determinations of cyclic AMP in the rat intestinal mucosa showed that the level of this substance was significantly higher in the presence than in the absence of SLS. The experimental conditions were as described for the absorption experiments. It is concluded that the data obtained support the idea of an increased level of cyclic AMP as the main basis for the effect of SLS on the absorption.
D000818:Animals; D001639:Bicarbonates / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D002794:Choline / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D007093:Imidazoles / Q000494:pharmacology; D007408:Intestinal Absorption / Q000187:drug effects*; D007413:Intestinal Mucosa / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism; D008823:Micelles; D009994:Osmolar Concentration; D010042:Ouabain / Q000494:pharmacology; D010637:Phenolsulfonphthalein / Q000378:metabolism; D011220:Pralidoxime Compounds / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology
D001639:Bicarbonates; D002712:Chlorides; D007093:Imidazoles; D008823:Micelles; D011220:Pralidoxime Compounds; D012967:Sodium Dodecyl Sulfate; D010042:Ouabain; D003994:Bucladesine; D012964:Sodium; D013806:Theophylline; D000242:Cyclic AMP; D010637:Phenolsulfonphthalein; D002794:Choline